Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
New therapeutic strategies that rely on TLR4 inhibition can counteract the formation of coronary clots in people with cardiovascular disease.
IL-17 molecules from the gut can influence autoimmune diseases in the central nervous system by regulating the gut microbiota.
Dietary fiber can influence the production of several microbial metabolites that may modify the human gut microbiome and, more in general, health.
Different gut metabolites can influence the Cryptosporidium parasite’s growth and invasion of intestinal cells. A new study published in mBio claims.
The interaction between newborns’ epithelia and the microbiota is crucial to the balance of the oral mucosa and it can have long-term health consequences.
TCGA allows to explore the role of tissue-resident microbiota in various cancer types and identifying predictive microbial biomarkers.
Immune responses to the gut microbiota can be used as biomarkers of clinical course in IBD or as targets for the treatment or prevention of the condition.
Decreased microbial diversity and increased abundance of Firmicutes phylum in the respiratory tract may be associated with an increased risk of lung cancer.
The findings suggest that delivery mode, rather than birth canal exposure, has a strong influence on the composition of the infant microbiota.
Modulating the gut microbiota could help to increase Plasmodium-specific immunity, thus reducing disease severity and malaria-associated mortality.
